| GNB2 — G Protein Subunit Beta 2 | |
|---|---|
| Symbol | GNB2 |
| Full Name | G Protein Subunit Beta 2 |
| Chromosome | 7q22.1 |
| NCBI Gene | 2783 |
| Ensembl | ENSG00000186470 |
| OMIM | 139311 |
| UniProt | P62879 |
| Protein | [GNB2 Protein](/proteins/gnb2) |
| Diseases | Neurodegeneration, Cancer, Immune Disorders |
| Inheritance | Autosomal Dominant (somatic variants in cancer) |
| Expression | Brain (cortex, hippocampus, cerebellum), Heart, Liver, Immune cells |
Gnb2 — G Protein Subunit Beta 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GNB2 (G Protein Subunit Beta 2) encodes the beta-2 subunit of heterotrimeric G proteins. G proteins transduce signals from cell surface receptors to downstream effectors, regulating diverse cellular processes including neuronal signaling, metabolism, and gene expression. The beta-gamma dimer (including GNB2) is essential for G protein signaling specificity and localization.
GNB2 functions as part of the Gβγ dimer:
GNB2 alterations are implicated in several neurological conditions:
Somatic GNB2 variants have been identified in:
GNB2 is expressed in immune cells and affects:
GNB2 is ubiquitously expressed:
In the brain, GNB2 is expressed in neurons and glia, with important roles in synaptic signaling.
The study of Gnb2 — G Protein Subunit Beta 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.